1Y Close · As of Aug 26, 2026
TiumBio operates in the Professional Services sector.
Legal name: TiumBio Co., Ltd.
In fiscal year 2025, TiumBio (321550) reported revenue of 12.3 billion KRW, up 80.9% from 6.8 billion KRW a year earlier.
Operating profit was -16.1 billion KRW and net income was -18.8 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 123.8 billion KRW, with a P/B of 3.28.
These figures can be verified in the DART filing (receipt no. 20260318000695).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 12.3B | -16.1B | -18.8B |
| 2024 | 6.8B | -18.7B | -23.5B |
| 2023 | 4.9B | -27.8B | -19.0B |
Checks
2 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Audit Opinion: Audit opinion: Unqualified (clean).
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-14 | Semi-Annual Report (2026.06) |